Importantly, understanding this novel mechanism of bone loss in CKD may help explain the abnormal bone at low levels of PTH, leading to CKD-specific treatment options to prevent bone fractures, a major cause of morbidity and mortality in CKD. Here, PTH is linked to chronic kidney disease.